Prolongation of central motor conduction time in chronic fatigue syndrome

Journal of Chronic Fatigue Syndrome

Volumn 4, Issue 2, 1998, Pages 23-32

  Hilgers, Arnold ^a   Frank, Johannes ^a   Bolte, Petra ^b  

^a Inst Angew Immunol U   (Germany)

^b Forschungsgruppe Neuroorthopadie   (Germany)

Author keywords

Central motor conduction time (CMCT); Central nervous system (CNS); Chronic Fatigue Syndrome (CFS); Magnetic stimulation; Motor evoked potential (MEP)

Indexed keywords

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM; CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; EVOKED MUSCLE RESPONSE; FEMALE; HUMAN; MAGNETIC STIMULATION; MAJOR CLINICAL STUDY; MALE; MOTOR NERVE CONDUCTION;

EID: 0031858871     PISSN: 10573321     EISSN: None     Source Type: Journal    
DOI: 10.1300/J092v04n02_03     Document Type: Article

References (30)

1. World Health Organisation. International Statistical Classification of Diseases and Related Health Problems. Tenth Revision. Geneva 1992: 424.
2. Buchwald D, Komaroff AL. Review of laboratory findings for patients with chronic fatigue syndrome. Rev Inf Dis 1991; 13: 12-18.
3. Manu P, Lane TJ, Matthews DA. The pathophysiology of chronic fatigue syndrome: Confirmations, contradictions, and conjectures. Int J Psychiat Med 1992; 22: 397-408.
4. Lloyd AR, Wakefield D, Hickie I. Immunity and the pathophysiology of chronic fatigue syndrome. Chronic fatigue syndrome. Wiley, Chichester (Ciba Foundation Symposium 173) 1993: 176-92.
5. Komaroff AL. Chronic fatigue syndromes: relationship to chronic viral infections. J Virol Meth 1988; 21: 3-10.
6. Hilgers A, Frank J. Chronic fatigue immundysfuncion syndrome bei 103 patienten: Diagnostik, befunde und therapie. Z Klin Med 1992; 47: 52-64.
7. Levy JA, Landay AL, Jessop C, Lennette E. Chronic fatigue syndrome: Is it a state of chronic immune activation against an infectious virus? In: Root, RK, MA Sande (eds.): Viral Infections: Diagnosis, Treatment and Prevention. Churchill Livingstone New York, Edinburgh, London, Melbourne, Tokyo 1993: 127-45.
8. Hilgers H, Frank J. Chronic fatigue syndrome: Immundysfunktion, erreger-und schadstoffbeteiligung sowie neurologische und kardiale Veränderungen. Wien Med Wochenschr 1994. 144: 399-406.
9. Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Straus SE, Jones JF, Dubois RE, Cunningham Rundles C, Pahwa S, Tosato G, Zegans LS, Purtilo DT, Brown N, Schooley RT, Brus I. Chronic fatigue syndrome: A working case definition. Ann Int Med 1988;108 (3): 387-389.
10. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A, International CFS study group. The chronic fatigue syndrome: A comprehensive approach to its definition and study. Ann Int Med 1994;121 (12):953-959.
11. Ichise M, Salit IE, Abbey SE, Chung DG, Gray B, Kirsh JC, Freedman M. Assessment of regional cerebral perfusion by 99TCm-HMPAO SPECT in chronic fatigue syndrome. Nucl Med Commun 1992; 13: 767-72.
12. Schwartz RB, Garada BM, Komaroff AL, Tice HM, Gleit M, Jolesz FA, Holman BL. Detection of intracranial abnormalities in patients with chronic fatigue syndrome: Comparison of MR imaging and SPECT. AJR 1994;162: 935-941.
13. Buchwald D, Cheney PR, Peterson DL, Henry B, Wormsley SB, Geiger A, Ablashi DV, Salahuddin SZ, Saxinger S, Biddle R, Kikinis R, Jolesz FA, Folks T, Balachandran T, Peter JB, Gallo RC, Komaroff AL. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpes-virus type 6 infection. Ann Intern Med 1992; 116: 103-13.
14. Mayr N, Baumgartner C, Zeitlhofer J, Deecke L. The sensitivity of transcranial cortical magnetic stimulation in detecting pyramidal tract lesions in clinically definite multiple sclerosis. Neurology 1991; 41: 566-9.
15. Benecke R, Knur R. Encephalomyelitis disseminata. In: Meyer, BU. (Hrsg): Die Magnetstimulation des Nervensystems. Grundlagen und Ergebnisse der klinischen und experimentellen Anwendung. Springer-Verlag Berlin Heidelberg New-York 1992: 243-58.
16. Ravnborg M, Liguori R, Christiansen P, Larsson H, Soelberg-Sorensen P. The diagnostic reliability of magnetically evoked motor potentials in multiple sclerosis. Neurology 1992; 42: 1296-1301.
17. Weyh T, Schreivogel K. Technische und physikalische Grundlagen. In: Meyer BU (Hrsg): Die Magnetstimulation des Nervensystems. Grundlagen und Ergebnisse der klinischen und experimentellen Anwendung. Springer-Verlag Berlin Heidelberg New-York 1992: 27-59.
18. Thompson PD, Rothwell JC, Day BL, Dressler D, Maertens de Noordhout D, Marsden CD. Mechanism of electrical and magnetic stimulation of human motor cortex. In: Chocroverty S. Magnetic Stimulation in Clinical Neurophysiology. Butterworth, Boston 1990: 121-43.
19. Claus D. Motorische Leitungszeit (motorisch evozierte Potentiale). In: Lowitzsch K, Maurer K, Hopf HC, Tackmann W, Claus D. Evozierte Potentiale bei Erwachsenen und Kindern. Georg Thieme Verlag Stuttgart New York 1993: 278-378.
20. Claus D. Central motor conduction: Methods and normal results. Muscle Nerve 1990; 13: 1125-32.
21. Dvorak J, Herdmann J, Theiler R. Magnetic transcranial brain stimulation: Painless evaluation of central motor pathways. normal values and clinical application in spinal cord diagnostics: upper extremities. Spine 1990; 15 (3): 155-60.
22. Ludolph AC, Wenning G, Masur H, Füratsch N, Elger CE. Die elektromagnetische Stimulation des Nervensystems. Normwerte im zentralen Nervensystem und Vergleich mit der elektrischen Stimulation. ZEEG EMG 1989; 20: 153-8.
23. Wehling, P. Die mögliche Rolle der Transkraniellen Magnetstimulation in der Diagnostik lumbosakraler Radikulopathien. Z Orthop 1991; 129: 6-11.
24. Murray NMF. Magnetic Stimulation of the brain: Clinical applications. In: Chocroverty S: Magnetic Stimulation in Clinical Neurophysiology. Butterworth, Boston 1990: 205-31.
25. Hess CW, Mills KR, Murray NMF. Entladungscharakteristika der durch transkranielle Kortexreizung aktivierten motorischen Einheiten in den Handmuskeln des Menschen. Z EEG EMG 1988; 19: 216-21.
26. Chung IY, Norris JG, Benveniste EN. Differential tumor necrosis factor a expression by astrocytes from experimental allergic encephalomyelitis - susceptible and - resistant rat strains. J Exp Med 1991; 173 (4): 801-11.
27. Patarca R, Klimas NG, Lugtendorf S, Antoni M, Fletcher MA. Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome: Interrelations with cellular sources and patterns of soluble immune mediator expression. Clin Infect Dis 1994; 18: S147-53.
28. Patarca R, Klimas N, Sandler D, Garcia MN, Fletcher MA. Interindividual immune status variation patterns in patients with chronic fatigue syndrome: Association with gender and the tumor necrosis factor system. J Chronic Fatigue Syndrome 1996; 2: 13-40.
29. Selmaj KW, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988; 23: 339-46.
30. Behan PO, Behan WMH, Bell EJ. The postviral fatigue syndrome - an analysis of the findings in 50 cases. J Infection 1985; 10: 211-22.